Kintayl Capital LP bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 200,000 shares of the pharmacy operator's stock, valued at approximately $2,234,000. Walgreens Boots Alliance makes up about 1.6% of Kintayl Capital LP's portfolio, making the stock its 23rd biggest position.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Curat Global LLC acquired a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth $27,000. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the 1st quarter worth $27,000. Colonial Trust Co SC boosted its position in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,297 shares in the last quarter. Central Pacific Bank Trust Division boosted its position in shares of Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 1,000 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 83.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 5,312 shares of the pharmacy operator's stock worth $50,000 after purchasing an additional 2,422 shares in the last quarter. Institutional investors own 58.59% of the company's stock.
Insider Buying and Selling at Walgreens Boots Alliance
In related news, Chairman Stefano Pessina acquired 832,258 shares of Walgreens Boots Alliance stock in a transaction on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman owned 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 17.50% of the company's stock.
Walgreens Boots Alliance Stock Performance
Shares of NASDAQ WBA traded down $0.02 during trading on Friday, reaching $11.49. 5,206,067 shares of the company traded hands, compared to its average volume of 18,823,798. The firm's fifty day simple moving average is $11.36 and its 200 day simple moving average is $11.02. The stock has a market cap of $9.95 billion, a P/E ratio of 6.02, a PEG ratio of 1.35 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $13.25. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The business had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The company's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $0.63 EPS. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms have recently weighed in on WBA. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $10.59.
Check Out Our Latest Stock Report on WBA
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access Sale